Susana Rodrigues

Enjoy!! researchgate.net/profile/Arumug…

This Wednesday, a new Talk Liver to Me podcast episode awaits you! This time, experts @tom_marjot, @MattiasMandorf1 & Cristina Ripoll break down the key takeaways from the Baveno VIII meeting. What’s changed in portal hypertension management, what reached consensus, and what’s still debated? Read more: easl.eu/event/baveno-v… #LiverTwitter #LiverX

During the inspiring ⁦@BavenoCoop⁩ VIII, it was great to meet up with some of the ⁦@AASLDtweets⁩ portal hypertension SIG VIII committee members. ⁦@Yujun__Wong⁩ @VirginiaHdezGea @NorthupHepTXP #AnahitaRabiee. Congrats to Anahita for your prize!

@AASLD Portal Hypertension SIG Steering Committee at Baveno-VIII @VirginiaHdezGea @RodriguesSu24 @NorthupHepTXP #AnahithaRabiee

⓹ Metabolic comorbidities (diabetes, obesity) further worsen prognosis and must be actively managed. ⓺ Sarcopenia/frailty: impact on cACLD natural history remains inconclusive ⓻ Surgery → ↑ risk of decompensation/ACLF (especially with CSPH). #BavenoVIII

RT @AEEHLiver: 🗣️Nuestro presidente Rafael Bañares participado, junto a @crisripol, esta mañana como moderador en el Panel 3 en #BavenoVIII…

cACLD and HCC - NITs ❌ if macrovascular invasion - Rule-out CSPH: possible in all stages (LSM ≤15 kPa + PLT≥150 G/L) => avoid endoscopy - Rule-in CSPH: ANTICIPATE±NASH highly suggestive ONLY in early HCC without large right liver nodules #BavenoVIII

Poor #oral #health associated with systemic #inflammation and unfavorable outcomes. What happens if #cirrhosis patient receives regular #dental #prophylaxis and #periodontal #maintenance? jhep-reports.eu/article/S2589-… @VCU @VCU_Nephrology @VAResearch @JHEP_Reports

📌 First meta-analysis on recompensation in decompensated cirrhosis 🔍 More common in viral etiologies & lower MELD 📉 Linked to lower risk of HCC & death ✅ A meaningful clinical endpoint Read more here: ow.ly/2qx150YvNUk #LiverTwitter @wong__yujun @BavenoCoop

HEY TEAM #LiverX !! ✈️to Baveno 🇮🇹 🔜 on Friday-Saturday (27-28 MARCH 2026) we will present the Baveno VIII consensus statements !! 👀 out & learn how to get your patient with #cirrhosis recompensated ♻️

🟣Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats 🔓#OpenAccess at👉jhep-reports.eu/article/S2589-… #LiverTwitter #LiverX #Cirrhosis

⏳ Final countdown: 2 weeks to #BavenoVIII‼️ 9⃣ expert panels across the full PH spectrum 📍 Baveno, Italy 🌐 Hybrid format — join in person or online 🔗 baveno8.org/registration Don’t miss it! Programme 👇

LAST DAY‼️ 🚨 Early-bird registration for #BavenoVIII closes TODAY (15 Dec)‼️ 🗓️ 27–28 March 2026 (👶 29 March) 📍 Baveno, Italy 🌐 Hybrid format — in person or online 🧠 Abstract submissions open until Jan 15 🔗 baveno8.org/registration 👇

🚨Just 10 days away ‼️ Join the VALDIG PSVD Meeting 2025 in Paris 🗓️ Dec 4–5 @ CNAM 💶 Onsite €150 | 💻 Online FREE 👉 Organized by EURO-VALDIG NET & FILFOIE 🔗 Registration → app.evalandgo.com/f/325218/4qE...📘 Updated program below 👇 #LiverTwitter

⏳ Just 5 months left for #BavenoVIII! 🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March) 📍 Baveno, Italy 🌐 The event will take place in a hybrid formula — both in person and online. 🧠 Call for abstracts is now open! 🔗 More info at: baveno8.org 🧵

Sarcopenia is common in cirrhosis So you should: 1. Recognize malnutrition 2. Address malnutrition 3. Promote exercise 4. Even supplement testosterone But don’t screen for it Not an independent mortality predictor journals.lww.com/hepcomm/fullte…

@docberza Thank you very much dear Annalisa! It’s a joy to be part of our team.

Big congratulations to my dear colleague and friend Susana Rodrigues for receiving the academic title of Privat Dozentin at the University of Bern. Our group is so proud of you!

Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing. Read the full review: nej.md/3OFrGZR

#GUTImage from the #GUTCommentary by Dr Iuliana Pompilia Radu on "Is mailed outreach and patient navigation a perfect solution to improve HCC screening?" via bit.ly/3YXsgYN #HCC

On 9th May I will take over as the 1st female Secretary General @EASLnews. I am looking for a partner to join me on my leadership journey and join our global hepatology platform🌎 E - Education A - Advocacy S - Science L - Leadership DM or 📞 for an informal chat. #livertwitter